Latest news articles

Added 2 months ago Congress news

EULAR 2019 | NEW BIOMARKERS FOR CARDIOVASCULAR RISK IN PATIENTS WITH JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS (JSLE)

ApoB:A1 ratio and metabolomic lipoprotein signatures identified as new biomarkers for cardiovascular risk in JSLE patients1

Added 6 months ago Drug news

EU filing of CCX 168 for vasculitis withdrawn.- ChemoCentryx + Vifor Fresenius

ChemoCentryx and Vifor Fresenius Medical Care Renal Pharma announced that in light of the upcoming availability of data from the...

Added 11 months ago Drug news

The TULIP 1 Phase III trial for anifrolumab in adult patients with moderate-to-severe systemic lupus erythematosus (SLE) did not meet the primary endpoint.- AstraZeneca

AstraZeneca and MedImmune, announced top-line results from the from the TULIP 1 Phase III trial for anifrolumab in adult patients...

Search all news articles for Systemic lupus erythematosus
 

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Chronic Lymphocytic Leukaemia (CLL)

Chronic Lymphocytic Leukaemia (CLL)

Refine your knowledge of chronic lymphocytic leukaemia (CLL) with information on pathophysiology, diagnosis, treatment options and more

+ 1 more

Transplantation

Transplantation

See information on best practice in solid organ transplantation, and expert discussions on related hot topics.

Load more

Guidelines

EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice

These are the first EULAR recommendations providing up-to-date guidance for the role of imaging in the diagnosis and monitoring of patients with (suspected) LVV.

Added 1 year ago

The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults

The aim of this guideline was to produce recommendations for the management of adult lupus patients in the UK that cover the diagnosis, assessment and monitoring of lupus and the treatment of mild, moderate and severe active lupus disease...

Added 1 year ago

Update of EULAR recommendations for the treatment of systemic sclerosis

These updated data-derived and consensus-derived recommendations will help rheumatologists to manage patients with SSc in an evidence-based way. These recommendations also give directions for future clinical research in SSc.

Added 1 year ago

Search all guidelines for Systemic lupus erythematosus
 

Journal articles

Novel therapies for immune-mediated inflammatory diseases: What can we learn from their use in rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, psoriasis, Crohn's disease and ulcerative colitis?

The past three decades have witnessed remarkable advances in our ability to target specific elements of the immune and inflammatory response, fuelled by advances in both biotechnology and disease knowledge.

Added 4 months ago

Trial of Tocilizumab in Giant-Cell Arteritis.

Background: Giant-cell arteritis commonly relapses when glucocorticoids are tapered, and the prolonged use of glucocorticoids is associated with side effects. The effect of the interleukin-6 receptor alpha inhibitor tocilizumab on...

Added 1 year ago

Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome.

Atypical hemolytic uremic syndrome (aHUS) is caused by alternative complement pathway dysregulation, leading to systemic thrombotic microangiopathy (TMA) and severe...

Added 3 years ago

Search all journal articles for Systemic lupus erythematosus
 

Clinical trials

An Efficacy and Safety Study of Tocilizumab (RoActemra/Actemra) in Participants With Giant Cell Arteritis (GCA)

This multicenter, randomized, double-blind, placebo-controlled, parallel-group study will evaluate the efficacy and safety of tocilizumab in participants with GCA. The study will consist of 2 parts...

Added 1 year ago

A Study of Belimumab Administered Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE) (BLISS-SC)

The purpose of this study is to evaluate the efficacy, safety and tolerability of belimumab administered subcutaneously (SC) to adult subjects with Systemic Lupus Erythematosus (SLE).

Added 8 years ago

Search all clinical trials for Systemic lupus erythematosus
 

CME

Dermatological emergencies in children

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
1
Registration required
1
Subscription fee
0
Search all CME for Systemic lupus erythematosus